Featured Article

Ken Getz of Tufts CSDD and Steve Young of CluePoints Discuss Stand Out Results from Recent RBQM Study

In part 2 of this video interview series, Ken Getz, executive director and research professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine and Steve Young, chief science officer, CluePoints highlight what stood out to them from the results of a recent study on RBQM adoption.

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Download
Press Release
CluePoints Announced as Fierce Life Sciences Innovation Awards Finalist
  • RBQM leader secures finalist position in the Data Analytics/Business Intelligence category at prestigious awards. WAYNE, PA...
Read More
Press Release
CluePoints Shortlisted for 2026 Scrip Awards Following 2023 and 2025 Wins
  • The two-time category winner secures finalist position in the Best Contract Research Organization (Specialist Providers) category....
Read More
Press Release
CluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical Company
  • Intelligent Query Detection, Medical & Safety Review and Intelligent Medical Coding are now generally available, extending...
Read More